VFPI
PFE icon

Vantage Financial Partners (Illinois)’s Pfizer PFE Stock Holding History

Vantage Financial Partners (Illinois)’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$495K Sell
17,696
-1,390
-7% -$38.3K 0.12% 74
2024
Q1 		$530K Sell
19,086
-4,864
-20% -$135K 0.14% 71
2023
Q4 		$690K Sell
23,950
-5,000
-17% -$151K 0.21% 63
2023
Q3 		$960K Buy
28,950
+500
+2% +$17.7K 0.55% 38
2023
Q2 		$1.04M Buy
28,450
+900
+3% +$35K 0.58% 37
2023
Q1 		$1.12M Buy
27,550
+1,400
+5% +$60.5K 0.66% 36
2022
Q4 		$1.34M Buy
26,150
+1,200
+5% +$57.5K 0.77% 33
2022
Q3 		$1.09M Buy
24,950
+1,800
+8% +$87.5K 0.71% 29
2022
Q2 		$1.21M Buy
23,150
+9,000
+64% +$459K 0.72% 31
2022
Q1 		$733K Buy
14,150
+950
+7% +$49.3K 0.38% 47
2021
Q4 		$779K Buy
13,200
+650
+5% +$32.2K 0.39% 46
2021
Q3 		$540K Buy
12,550
+1,300
+12% +$57.6K 0.29% 54
2021
Q2 		$441K Buy
11,250
+1,100
+11% +$42.8K 0.25% 58
2021
Q1 		$368K Buy
10,150
+900
+10% +$32K 0.21% 59
2020
Q4 		$340K Sell
9,250
-737
-7% -$27K 0.2% 59
2020
Q3 		$348K Hold
9,987
– – 0.21% 59
2020
Q2 		$310K Hold
9,987
– – 0.19% 55
2020
Q1 		$309K Hold
9,987
– – 0.22% 50
2019
Q4 		$371K Hold
9,987
– – 0.22% 58
2019
Q3 		$340K Hold
9,987
– – 0.23% 55
2019
Q2 		$410K Sell
9,987
-569
-5% -$22.6K 0.26% 54
2019
Q1 		$425K Hold
10,556
– – 0.28% 47
2018
Q4 		$437K Hold
10,556
– – 0.32% 44
2018
Q3 		$441K Sell
10,556
-4,954
-32% -$191K 0.28% 49
2018
Q2 		$534K Buy
15,510
+106
+0.7% +$3.62K 0.35% 43
2018
Q1 		$519K Sell
15,404
-1,687
-10% -$58K 0.36% 38
2017
Q4 		$588K Sell
17,091
-4,321
-20% -$147K 0.39% 38
2017
Q3 		$726K Sell
21,412
-1,370
-6% -$44K 0.51% 29
2017
Q2 		$725K Buy
22,782
+6,158
+37% +$194K 0.51% 29
2017
Q1 		$435K Sell
16,624
-6,264
-27% -$197K 0.31% 36
2016
Q4 		$705K Buy
+22,888
New +$699K 0.63% 14

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vantage Financial Partners (Illinois)'s PFE Position: Q2 2024 in Review

Vantage Financial Partners (Illinois) reduced its Pfizer (PFE) stake by 7.3% in Q2 2024, selling an estimated $38.3K and leaving 17,696 shares worth $495K. The position accounts for 0.12% of the portfolio, ranked #74.

Vantage Financial Partners (Illinois) first reported a position in PFE in Q4 2016 and has held it in 31 quarters since. The position peaked at $1.34M in Q4 2022. 2,874 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

  • Vantage Financial Partners (Illinois) held 17,696 shares of Pfizer worth $495K as of Q2 2024.
  • Vantage Financial Partners (Illinois) sold 1,390 Pfizer shares in Q2 2024, an estimated $38.3K.
  • Pfizer made up 0.12% of Vantage Financial Partners (Illinois)'s portfolio in Q2 2024, its #74 holding.
  • Vantage Financial Partners (Illinois) first reported a position in Pfizer in Q4 2016 and has held it in 31 quarters since.
  • Vantage Financial Partners (Illinois)'s Pfizer position peaked at $1.34M in Q4 2022.
  • 2,874 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on Vantage Financial Partners (Illinois)'s 13F filing for Q2 2024, filed 14 Aug 2024.